It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas.
VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.
Try our free search of constantly updated quotations and proverbs database.
Letter "H" » Hamilton Moses Quotes
«If we're soon going to be spending $100 billion a year, we'd better have treatments that work over a long period of time against diseases that are important today and will be more important tomorrow. If we don't know those conditions are satisfied, we can't judge whether we're getting our money's worth,»
«We were surprised that the increase has been as steady over the decade and as large as it has been.»
«[Part of this enthusiasm has stemmed from recent scientific advances, especially the completion of the human genome.] That pushed us in the 1990s to do what became at that point technologically feasible, ... It added to the momentum.»
«On the commercial side, clearly all of the three major types of companies -- traditional pharmaceutical companies, biotechnology companies and medical device companies -- view health and medicine as a growing market,»
«It raises the question ... are we getting our money's worth? Are we capturing the full value of that significant investment?»
«For all sponsors, the challenge is patience. Biomedical research is an inherently high risk and lengthy process,»
«We've seen growth and a real doubling of funding in all sectors. The proportions are really unchanged over the decade, with roughly 60 percent coming from industry and the remainder coming from government and foundations.»
«There aren't a lot of diseases where we can point to and say we have an answer today that we didn't have a decade ago.»
«[Still,] the doubling over a decade of total spending by U.S. public and private research sponsors in real, inflation-adjusted terms should be reassuring to those who fear that financial sponsorship for research is not paralleling scientific opportunity, ... It is also reassuring that spending on health and biomedical science research by companies and government is not following reductions in research and development in other industries or reduced support for other areas of science.»